Biblio
Export 170 results:
[ Author
Filters: First Letter Of Last Name is K [Clear All Filters]
“PET Tau and Amyloid-β Burden in Mild Alzheimer's Disease: Divergent Relationship with Age, Cognition, and Cerebrospinal Fluid Biomarkers.”, J Alzheimers Dis, vol. 60, no. 1, pp. 283-293, 2017.
, “Blood-Based ATN Biomarkers of Alzheimer's Disease: A Meta-Analysis.”, J Alzheimers Dis, vol. 79, no. 1, pp. 177-195, 2021.
, “Aβ42/Aβ40 and Aβ42/Aβ38 Ratios Are Associated with Measures of Gait Variability and Activities of Daily Living in Mild Alzheimer's Disease: A Pilot Study.”, J Alzheimers Dis, vol. 65, no. 4, pp. 1377-1383, 2018.
, “Gene Ontology Curation of Neuroinflammation Biology Improves the Interpretation of Alzheimer's Disease Gene Expression Data.”, J Alzheimers Dis, vol. 75, no. 4, pp. 1417-1435, 2020.
, “Long-Term Cognitive Decline in Dementia with Lewy Bodies in a Large Multicenter, International Cohort.”, J Alzheimers Dis, vol. 57, no. 3, pp. 787-795, 2017.
, “Diagnostic Value of Diffusion Tensor Imaging and Positron Emission Tomography in Early Stages of Frontotemporal Dementia.”, J Alzheimers Dis, vol. 63, no. 1, pp. 239-253, 2018.
, “Neuropsychological Symptoms in Sporadic Creutzfeldt-Jakob Disease Patients in Germany.”, J Alzheimers Dis, vol. 59, no. 1, pp. 329-337, 2017.
, “Yoga Prevents Gray Matter Atrophy in Women at Risk for Alzheimer's Disease: A Randomized Controlled Trial.”, J Alzheimers Dis, vol. 87, no. 2, pp. 569-581, 2022.
, “Odor Identification Ability Predicts PET Amyloid Status and Memory Decline in Older Adults.”, J Alzheimers Dis, vol. 62, no. 4, pp. 1759-1766, 2018.
, “Physical Activity and Trajectory of Cognitive Change in Older Persons: Mayo Clinic Study of Aging.”, J Alzheimers Dis, vol. 79, no. 1, pp. 377-388, 2021.
, “Leisure-Time Physical Activity and the Risk of Incident Dementia: The Mayo Clinic Study of Aging.”, J Alzheimers Dis, vol. 63, no. 1, pp. 149-155, 2018.
, “FDG-PET and Neuropsychiatric Symptoms among Cognitively Normal Elderly Persons: The Mayo Clinic Study of Aging.”, J Alzheimers Dis, vol. 53, no. 4, pp. 1609-16, 2016.
, “Inhibition of Histone Deacetylase 3 Restores Amyloid-β Oligomer-Induced Plasticity Deficit in Hippocampal CA1 Pyramidal Neurons.”, J Alzheimers Dis, vol. 51, no. 3, pp. 783-91, 2016.
, “Visually Identified Tau 18F-MK6240 PET Patterns in Symptomatic Alzheimer's Disease.”, J Alzheimers Dis, vol. 88, no. 4, pp. 1627-1637, 2022.
, “Varying Degrees of Temporoparietal Hypometabolism on FDG-PET Reveal Amyloid-Positive Logopenic Primary Progressive Aphasia is not a Homogeneous Clinical Entity.”, J Alzheimers Dis, vol. 55, no. 3, pp. 1019-1029, 2017.
, “Polypharmacy and Potentially Inappropriate Medication in People with Dementia: A Nationwide Study.”, J Alzheimers Dis, vol. 63, no. 1, pp. 383-394, 2018.
, “Promoting Successful Cognitive Aging: A Ten-Year Update.”, J Alzheimers Dis, vol. 81, no. 3, pp. 871-920, 2021.
, “The Pitfall of Behavioral Variant Frontotemporal Dementia Mimics Despite Multidisciplinary Application of the FTDC Criteria.”, J Alzheimers Dis, vol. 60, no. 3, pp. 959-975, 2017.
, “Association of Gait Speed, Psychomotor Speed, and Dementia.”, J Alzheimers Dis, vol. 60, no. 2, pp. 585-592, 2017.
, “Sex-Dependent Associations of Serum Uric Acid with Brain Function During Aging.”, J Alzheimers Dis, vol. 60, no. 2, pp. 699-706, 2017.
, “The Alzheimer's Disease Assessment Scale-Cognitive Subscale (ADAS-Cog): Modifications and Responsiveness in Pre-Dementia Populations. A Narrative Review.”, J Alzheimers Dis, vol. 63, no. 2, pp. 423-444, 2018.
, “Is the p3 Peptide (Aβ17-40, Aβ17-42) Relevant to the Pathology of Alzheimer's Disease?1.”, J Alzheimers Dis, vol. 74, no. 1, pp. 43-53, 2020.
, “Tau Rather than TDP-43 Proteins are Potential Cerebrospinal Fluid Biomarkers for Frontotemporal Lobar Degeneration Subtypes: A Pilot Study.”, J Alzheimers Dis, vol. 55, no. 2, pp. 585-595, 2017.
, “Impact of Omega-3 Fatty Acid Supplementation on Memory Functions in Healthy Older Adults.”, J Alzheimers Dis, vol. 51, no. 3, pp. 713-25, 2016.
, “Insights into the Pathophysiology of Alzheimer's Disease and Potential Therapeutic Targets: A Current Perspective.”, J Alzheimers Dis, vol. 91, no. 2, pp. 507-530, 2023.
,